Related references
Note: Only part of the references are listed.Endometrial cancer: Molecular markers and management of advanced stage disease
Rebecca C. Arend et al.
GYNECOLOGIC ONCOLOGY (2018)
Therapeutic Opportunities of Targeting Histone Deacetylase Isoforms to Eradicate Cancer Stem Cells
Peng-Chan Lin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Investigation of New Therapeutic Targets in Undifferentiated Endometrial Sarcoma
Min-Hyun Baek et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2017)
HDAC Inhibitors and RECK Modulate Endoplasmic Reticulum Stress in Tumor Cells
Yun Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Histone Deacetylase Inhibitors as Anticancer Drugs
Tomas Eckschlager et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approaches
C. C. Wong et al.
ONCOGENE (2017)
Assessing sirtuin expression in endometrial carcinoma and non-neoplastic endometrium
Carla Bartosch et al.
ONCOTARGET (2016)
Histone deacetylase inhibitor, Romidepsin (FK228) inhibits endometrial cancer cell growth through augmentation of p53-p21 pathway
Lu-Hong Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Anticancer Effects of a New SIRT Inhibitor, MHY2256, against Human Breast Cancer MCF-7 Cells via Regulation of MDM2-p53 Binding
Eun Young Park et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2016)
Biological Effect of a Hybrid Anticancer Agent Based on Kinase and Histone Deacetylase Inhibitors on Triple-Negative (MDA-MB231) Breast Cancer Cells
Mariangela Librizzi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
P53 and Sirt1: Routes of metabolism and genome stability
Stefania Gonfloni et al.
BIOCHEMICAL PHARMACOLOGY (2014)
A Novel Sirtuin 2 ( SIRT2) Inhibitor with p53-dependent Pro- apoptotic Activity in Non- small Cell Lung Cancer*
Gesine Hoffmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Molecular pathology of endometrial carcinoma
Xavier Matias-Guiu et al.
HISTOPATHOLOGY (2013)
SIRT1 represses estrogen-signaling, ligand-independent ER alpha-mediated transcription, and cell proliferation in estrogen-responsive breast cells
Robert L. Moore et al.
JOURNAL OF ENDOCRINOLOGY (2013)
SIRT1 Is Downregulated in Gastric Cancer and Leads to G1-phase Arrest via NF-κB/Cyclin D1 Signaling
Qing Yang et al.
MOLECULAR CANCER RESEARCH (2013)
Molecular Mechanism of SAHA on Regulation of Autophagic Cell Death in Tamoxifen-Resistant MCF-7 Breast Cancer Cells
Young Ju Lee et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2012)
Sirtinol, a class III HDAC inhibitor, induces apoptotic and autophagic cell death in MCF-7 human breast cancer cells
Jing Wang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Sirtuin 1 (SIRT1) and steroid hormone receptor activity in cancer
R. L. Moore et al.
JOURNAL OF ENDOCRINOLOGY (2012)
SIRT Inhibitors Induce Cell Death and p53 Acetylation through Targeting Both SIRT1 and SIRT2
Barrie Peck et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect
E. Lara et al.
ONCOGENE (2009)
A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells
Mee Young Ahn et al.
GYNECOLOGIC ONCOLOGY (2008)
An overview of epigenetic assays
J. Tyson DeAngelis et al.
MOLECULAR BIOTECHNOLOGY (2008)
Human SIRT1: A potential biomarker for tumorigenesis?
Chang-Su Lim
CELL BIOLOGY INTERNATIONAL (2007)
Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas
H Duan et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells
N Takai et al.
CLINICAL CANCER RESEARCH (2004)
Acetylation of p53 inhibits its ubiquitination by Mdm2
MY Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Apicidin, a histone deacetylase inhibitor, induces apoptosis and Fas/Fas ligand expression in human acute promyelocytic leukemia cells
SH Kwon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)